Orange County Convention Center
Orlando, Fla.
Nov. 14-18, 2009
Decoding the entire human genome sequence has ushered in a new era in science and health care and revolutionized our approach to human disease. The speed of discovery has brought new challenges and the International Congress will address the latest advances in cardiovascular genetics and genomics.
By becoming an AHA/ASA Professional Member, you could save up to $300 on Sessions registration.
Topics of this year’s Congress include:
- National and Multi-National Genetics Research Networks: Lessons Learned
- Epigenetic Control of Cardiovascular Disease
- Genetic Reprogramming to Model Human Cardiovascular Disease
- Deciphering Structural Variation in the Genome
- Integrative Genomic Studies: From Fish to Man
- Single Gene Disorders – Impact on Clinical Care
- HapMap and Beyond - Bioinformatic Resources for Cardiovascular Genomics
- Quantification by Mass Spectrometry
- Current Status of Genetic Testing to Diagnose Cardiomyopathies
- Analysis Challenges in Genetics Association Studies
- Consumer Driven Genomics
- Genome-wide Association Study: Discoveries and Challenges
- Genome-Guided Therapies for Cardiovascular Disease
- Genetics & Genomics Decoded: Update in CV Genetics and Genomics
- New Approaches for CVD Biomarkers: Search, Quantification and Characterization
- Genetically Driven Personalized Pharmacotherapy: What's Here, What's Coming and When to Adopt into Practice
“The American Heart Association’s International Congress on Genetics and Genomics of Cardiovascular Disease is a unique opportunity for scientists and physicians throughout the world to present and discuss the latest advances in the field of cardiovascular genomics.”
Seema Mital, M.D., FAHA
Co-Chair, Program Subcommittee
2009 International Congress on Genetics and Genomics of Cardiovascular Disease
Print
Email
